The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 52 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antibodies, Monoclonal  [Clear All Filters]
2017
Athyros, V. G., Tziomalos K., Doumas M., Sfikas G., & Karagiannis A. (2017).  The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.. Curr Pharm Des. 23(10), 1477-1483.
Kyriakidis, I., Tragiannidis A., Zündorf I., & Groll A. H. (2017).  Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.. Mycoses. 60(8), 493-507.
Tragiannidis, A., Kyriakidis I., Zündorf I., & Groll A. H. (2017).  Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.. Mycoses. 60(4), 222-229.
Laskari, K., Boura P., Dalekos G. N., Garyfallos A., Karokis D., Pikazis D., et al. (2017).  Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.. J Rheumatol. 44(1), 102-109.
Gavriatopoulou, M., Kastritis E., Kyrtsonis M-C., Vassilakopoulos T. P., Roussou M., Fotiou D., et al. (2017).  Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.. Leuk Lymphoma. 58(6), 1506-1508.
Tziomalos, K. (2017).  The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.. Curr Pharm Des. 23(10), 1495-1499.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.